本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

再鼎医药

21.75
+0.02000.09%
成交量:50.43万
成交额:1,103.03万
市值:24.20亿
市盈率:-11.31
高:22.19
开:21.60
低:21.60
收:21.73
52周最高:44.34
52周最低:21.25
股本:1.11亿
流通股本:1.09亿
量比:0.60
换手率:0.46%
股息:- -
股息率:- -
每股收益(TTM):-1.9229
每股收益(LYR):-2.5984
净资产收益率:-28.97%
总资产收益率:-13.29%
市净率:3.18
市盈率(LYR):-8.37

数据加载中...

2025/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/18

重要事件披露

Form 8-K - Current report
2025/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

重要事件披露

Form 8-K - Current report
2025/04/19

SEC问询函

Form CORRESP - Correspondence
2025/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities